World J Gastroenterol
July 2024
This letter to the editor relates to the study entitled "Tenofovir amibufenamide tenofovir alafenamide for treating chronic hepatitis B: A real-world study", which was recently published by Peng . Hepatitis B virus infection represents a significant health burden worldwide and can lead to cirrhosis and even liver cancer. The antiviral drugs currently used to treat patients with chronic hepatitis B infection still have many side effects, so it is crucial to identify safe and effective drugs to inhibit viral replication.
View Article and Find Full Text PDF